Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Art Vandelay AIA who wrote (2815)	5/18/1999 1:25:00 PM
From: Andy Goett	Read Replies (2) of 10280

Last night on one of the network news broadcasts (I forget which), there was a piece on a new treatment for allergies. It involves taking injections once a month to block allergic reactions. While it is still under development, the reporter said that the drug is very effective, quick acting, and that there are no apparent side effects. The reporter said that the developers expect the drug to be available within three years. I know that there has been some discussion of this drug or a similar one on this thread in the past. I recall that its potential was downplayed because it requires taking injections and for other technical reasons that I don't understand. However, the news piece last night sounded much more positive. My question is how much of a threat is there that this drug (or some other anti-allergy research, for that matter) will make several of the "improved" antihistimine drugs that Sepracor is working on obsolete?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next